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Abstract
Bovine leukemia virus (BLV) is associated with the most common neoplastic disease of cattle. BLV has a silent 
dissemination in the herd due to infected cell exchange, thus the concentration of BLV-infected cells in blood should 
play a major role in the success of viral transmission. Genes from Bovine leukocyte antigen (BoLA), the MHC system 
of cattle, are associated with genetic resistance and susceptibility to a wide range of diseases, and also with production 
traits. Some BoLA DRB3.2 allele polymorphisms in Holstein cattle have been associated with resistance or susceptibility 
to BLV-disease development, or with proviral load (PVL). This investigation studied 107 BLV-infected Argentinean 
Holstein dairy cows, all of them belonging to one herd. PVL was analysed by qPCR and animals were classified as high 
proviral load (HPVL, N = 88) and low proviral load (LPVL, N = 19), and BoLA DRB3.2 alleles were genotyped. Alleles 
BoLA DRB3.2*1501 and *1201 were significantly associated with HPVL (p = 0.0230 and p = 0.0111 respectively), while 
allele BoLA DRB3.2*0201 was significantly associated with LPVL (p = 0.0030). The present study aims at contributing 
to the knowledge of the association between BoLA polymorphism and development of a BLV infection profile. Genes 
that best explain the PVL in this population resulted BoLA DRB3.2*0201 (as a protection factor) and *1501 (as a risk 
factor). Allelic differences may play an important role in the development of effective immune responses. A better 
understanding of how BoLA polymorphism contributes to these responses and the establishment of a BLV status is 
desirable to schedule and evaluate control measures.
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Resumo
O vírus da leucemia bovina (BLV) está associado à doença neoplásica mais comum do gado bovino. O BLV tem uma 
disseminação silenciosa no rebanho devido à troca de células infectadas, assim, a concentração de células BLV infectadas 
no sangue deve desempenhar um papel importante no sucesso da transmissão viral. Os genes do antígeno leucocitário 
bovino (BoLA), sistema MHC do gado bovino, estão associados à resistência genética e à susceptibilidade a uma ampla 
gama de doenças, bem como às características da produção. Alguns polimorfismos de alelos de BoLA DRB3.2 em 
bovinos Holstein têm sido associados à resistência ou susceptibilidade ao desenvolvimento da doença BLV, ou com 
carga proviral (PVL). Esta investigação avaliou 107 vacas leiteiras da raça Holstein argentina infectadas com BLV e 
pertencentes a um único rebanho. A PVL foi analisada por qPCR, os animais foram classificados em alta carga proviral 
(HPVL, N = 88) e baixa carga proviral (LPVL, N = 19), e os alelos BoLA DRB3.2 foram genotipados. Os alelos BoLA 
DRB3.2*1501 e *1201 estavam significativamente relacionados à HPVL (p = 0,0230 e p = 0,0111, respectivamente), 
enquanto o alelo BoLA DRB3.2*0201, à LPVL (p = 0,0030). O objetivo deste estudo é contribuir para o conhecimento 
da associação entre o polimorfismo de BoLA e o desenvolvimento de infecção por BLV. Os genes que melhor explicam 
a PVL na população analisada resultaram em BoLA DRB3.2*0201 (como fator de proteção) e *1501 (como fator de 
risco). As diferenças alélicas podem desempenhar um papel importante no desenvolvimento de respostas imunitárias 
eficazes. Uma melhor compreensão de como o polimorfismo BoLA contribui para estas respostas e o estabelecimento 
de um estado BLV é desejável para agendar e avaliar as medidas de controle.
Palavras-chave: BLV. Carga proviral. Polimorfismo do BoLA DRB3.
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Introduction 
Bovine leukemia virus (BLV) shares the genomic 
organization structure with T-cell tropic viruses from 
primates (human and simian), and constitute a unique 
subgroup within the Retroviridae family, characterized 
by distinct genetic content, genomic organization, and 
strategy for gene expression (COFFIN, 1996). BLV is 
associated with enzootic bovine leucosis (EBL), which is the 
most common neoplastic disease of cattle. Most infected 
cattle remain asymptomatic. By contrast, approximately 
30% of cattle develop persistent lymphocytosis (PL), 
which is characterized as the polyclonal expansion of 
non-neoplastic CD5+ B-lymphocytes. PL often precedes 
tumorigenesis but is usually regarded as clinically healthy. 
After a latency period of 1-8 years, less than 10% of 
infected cattle develop EBL, which is a malignant CD5+ 
B-cell lymphoma (FERRER, 1980; GILLET et al., 2007). 
BLV has a silent dissemination in the herd due to infected 
cell exchange (HOPKINS; DIGIACOMO, 1997), thus the 
concentration of BLV-infected cells in blood should play a 
major role in the success of viral transmission. Even though 
PL cattle are considered the most risky for transmission, 
asymptomatic animals may also play a role depending on 
their proviral load (JULIARENA et al., 2007).
The major histocompatibility complex (MHC) 
molecules are responsible for presentation of processed 
antigen peptides to T cells, and thereby an adaptive 
immune response to specific pathogens is trigged. The high 
degree of polymorphism of the MHC molecules enables 
the presentation of a wide array of peptides that differ in 
their length and sequence. Thus, the nature and strength 
of the immune responses depend on the peptide and the 
MHC molecules, and may influence disease progression 
(AMILLS et al., 1998). Bovine leukocyte antigen (BoLA), 
the MHC system of cattle, is highly polymorphic. 
Functionally, the BoLA class II gene is classified into two 
groups, DR and DQ. The DRA and DRB3 gene products 
form the DR molecule, as DRB3 is the only functional DRB 
gene within BoLA (TAKESHIMA; AIDA, 2006).
Genes from BoLA are remarkably attractive to animal 
breeders and veterinary geneticist, and polymorphism in 
BoLA genes has been relatively well studied. These genes 
are associated with genetic resistance and susceptibility to 
a wide range of diseases, including mastitis (DIETZ et al., 
1997; RUPP et al., 2007; YOSHIDA et al., 2009; YOSHIDA 
et al., 2012), dermatophilosis (MAILLARD et al., 2002), 
tick-borne diseases (DUANGJINDA et al., 2013), infection 
with Neospora caninum (SCHWAB et al., 2009), African 
trypanosome species (KARIMURIBO et al., 2011), and 
Theileria annulata (GLASS et al., 2012b). Moreover, BoLA 
appears to influence other traits such as milk yield, growth 
and reproduction, and variations in immune responses to 
antigens (TAKESHIMA; AIDA, 2006) and even vaccine 
peptides (GARCIA-BRIONES et al., 2000; GLASS et al., 
2012a).
The greatest amount of evidence linking BoLA gene 
polymorphisms and disease outcome is given by BLV 
infection. First evidences revealed an association between 
resistance or susceptibility to PL and BoLA A class I alleles 
(LEWIN; BERNOCO, 1986); however, these associations 
were relatively weak at population levels and different BoLA 
A alleles had significant effects in different breeds (LEWIN 
et al., 1988; STEAR et al., 1988). Subsequent studies showed 
that resistance and susceptibility to PL map more closely 
to MHC class II BoLA DRB3.2 gene than to BoLA A locus 
(ESTEBAN et al., 2009). Thus, most studies have focused on 
BoLA DRB3.2 allele polymorphisms in Holstein cattle, and 
their relationship with disease. Some alleles were associated 
with resistance to PL or to BLV-induced lymphosarcoma, 
or the capability of controlling the number of BLV-infected 
cells, while other alleles were associated with susceptibility 
to PL (XU et al., 1993; ZANOTTI et al., 1996; MIRSKY 
et al., 1998; PANEI et al., 2009; NIKBAKHT BRUJENI et 
al., 2016). When BLV-infected animals were characterized 
into two profiles of infection – high and low proviral load 
(HPVL and LPVL respectively) (JULIARENA et al., 2007), 
BoLA DRB3.2 *0902 allele was the strongest associated with 
LPVL profile, while *1501 or 03 allele showed a significant 
association with HPVL in carrier animals (JULIARENA 
et al., 2008). Miyasaka et al. (2013) also analyzed the effect 
of BoLA DRB3.2 alleles on proviral load in Japanese cattle 
and found that *0902 and *1101 alleles were associated with 
LPVL and *1601 allele with HPVL and identified BoLA 
class II haplotypes that correlated with different PVL status.
In the present investigation we analysed whether HPVL 
or LPVL status in the BLV-infected animals from the herd 
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under study were associated with specific BoLA DRB3.2 
alleles. This study aims at contributing to the knowledge 
of the association between BoLA polymorphism and 
development of a BLV infection profile.
Material and Methods
Sample collection
Blood samples were obtained from 107 BLV-infected 
Argentinean Holstein (Holando-Argentino) dairy cows 
belonging to a herd from the Tandil region (Provincia de 
Buenos Aires, Argentina). All animals were healthy and 
milking (between second and third lactation period) and 
although the pedigree information was not complete for 
3% of them, they came from at least 51 and 87 different 
bulls and cows, respectively. Serological BLV status was 
determined by testing plasma for anti-gp51 antibodies 
by ELISA 108 (GUTIERREZ et al., 2001). For peripheral 
blood mononuclear cells (PBMCs) separation, 10 mL 
blood samples were collected in heparinized syringes by 
jugular venipuncture. Blood samples were transferred to 
15 mL tubes and centrifuged for 15 min at 3800 rpm at 
4°C. Buffy coat was mixed with 11 mL of cold ammonium 
chloride buffer (150 mM NH4Cl, 8 mM Na2CO3, and 6mM 
EDTA) for red blood cells lysis. PBMCs were obtained 
by centrifugation at 3000 rpm for 10min at 4°C. Cells 
were washed with PBS and centrifuged at 2500 rpm for 7 
min at 4°C. PBMCs pellets were stored at -20°C for DNA 
extraction.
DNA extraction
DNA from PBMCs was extracted using Qiagen columns 
(QIAamp DNA Mini Kit) according to the manufacturer’s 
protocol. DNA was eluted in 50 ml of water. The 
concentration and purity of DNA were determined by the 
OD value at 260nm and 260/280 coefficient respectively in 
a NanoDrop 2000 Spectrophotometer (Thermo Scientific). 
The purified DNAs were stored at -20°C until use.
Proviral load determination by real-time PCR (qPCR)
The absolute quantification method by qPCR used for 
proviral load (PVL) determination was the one described 
by Farias et al. (2016). The standard curve was constructed 
using a plasmid carrying one copy of the entire BLV 
genome under control of its own promoter LTR (pBLV), 
with six 10-fold serial dilutions of pBLV, containing 1 
million to 10 BLV copies. The qPCR conditions for pol 
amplification were previously described (FARIAS et al., 
2016). Each reaction contained 30 ng of DNA from BLV-
infected animals. The standard curve and non-template 
control were included in each run. Experiments were 
always performed in triplicate. BLV-positive animals 
were classified as high proviral load (HPVL) (> 1000 BLV 
copies/reaction) and low proviral load (LPVL) (< 100 BLV 
copies/reaction). Before classifying the animals into each 
group, the proviral load was evaluated twice at 6-months 
intervals, in order to confirm their PVL. Eighty-eight out 
of 107 animals were HPVL, while the remaining 19 proved 
to be LPVL.
BoLA DRB3.2 genotyping
PCR reactions were performed in a final volume of 15 
L, where the volume mixture contained: ng of genomic 
DNA, 0.03 X PCR buffer (Mg2+ plus), 0.3 M of each primer 
(HL030; 5’-ATCCTCTCTCTGCAGCACATTTCC-3’, and 
HL031; 5’-TTTAAATTCGCGCTCACCTCGCCGCT-3’), 
0.2 mM of dNTP and 0.75U Paq5000® DNA Polymerase 
(Agilent Technologies, Stratagene) and water up to a total 
volume of 15 μL. Conditions for amplification were 94°C 
for 3 min, followed by 35 cycles of 20 s at 94°C, 20 s at 60°C 
(annealing temperature), and 1min at 72°C. Reactions were 
finished with a 72°C, 5-min extension. PCR reactions were 
performed in a Mastercycler (Eppendorf®) thermocycler. 
Amplified fragments of DNA were visualized in a 1% 
agarose gel and sequenced using BigDye® chemistry on 
an ABI3130xl sequencer (Applied Biosystems) following 
the manufacturer’s protocol. Sequencing reactions were 
performed in both senses using the same primers as for 
PCR reactions, in a total volume of 10 L containing a 
1:10 dilution of the PCR product as template and 0.1M of 
primer, in addition to the mix and buffer 5X of BigDye® 
Terminator kit. The sequence analysis and obtaining 
genotypes was performed using Haplofinder (BAXTER 
et al., 2008).
Statistics analysis
Association between different BoLA DRB3.2 alleles and 
proviral load was estimated by Chi2 test or exact Fisher 
test, as appropriate, implemented by PROC FREQ (SAS 
v9.3, Institute Inc., Cary, NC, USA). With genes that were 
significant to the bivariate analysis logistic regression was 
performed in order to identify genes that best explain the 
CPV, using the PROC LOGISTIC (SAS v9.3).
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Results
Analysis of BoLA DRB3.2 genotyping
After genotyping, a total of 18 BoLA DRB3.2 alleles 
defined according to the ISAG BoLA Nomenclature 
Committee were identified in these Argentinean Holstein 
cattle. The five most frequently alleles were BoLA 
DRB3.2*1001 (17.29%), *1501 (16.36%), *1101 (14.95%), 
*0101 (12.15%), and *1201 (11.21%) (Table 1). We 
found 47 genotypes, where BoLA DRB3.2*1001 + BoLA-
DRB3.2*1501 (9 animals, 18.75%), BoLA DRB3.2*1101 
+ BoLA DRB3.2*1501 (8 animals, 16.67%), and BoLA 
DRB3.2*1001 + BoLA DRB3.2*1201 (6 animals, 12.5%) 
were the most frequent in the population (data not shown).
Table 1 – BoLA DRB3.2 allele frequency in the studied 
population
Alelle No. %
*1001 37 17.29
*1501 35 16.36
*1101 32 14.95
*0101 26 12.15
*1201 24 11.21
*0201 14 6.54
*0902 9 4.21
*0601 7 3.27
*1801 6 2.80
*2703 5 2.34
*14011 5 2.34
*3103 4 1.87
*1001/1002 3 1.40
*1402 2 0.93
*2707 2 0.93
*0701 1 0.47
*1701 1 0.47
*2003 1 0.47
Association between BoLA DRB3.2 alleles and 
proviral load (PVL)
BLV-positive cattle (N = 107) were categorized into two 
groups according to their PVL by qPCR: 88 had HPVL 
and 19 had LPVL. The presence or absence of each BoLA 
DRB3.2 allele in this cattle population was analysed in 
association with PVL (Table 2). No significant association 
was observed between PVL and alleles having frequency 
lower than 10%. Amongst alleles with higher frequency 
in the population, *1501 and *1201 were significantly 
associated with HPVL (p = 0.0230 and p = 0.0111 
respectively), while allele *0201 was significantly associated 
with LPVL (p = 0.0030) (Table 2).
Table 2 – Association between BoLA DRB3.2 alleles and 
proviral load (PVL)
Evaluated 
allele PVL
Presence 
(No.)
Absence 
(No.)
OR
(CI 
95%)
p value
*1001 HPVLLPVL
33
3
56
16 0.0830
a
*1501 HPVLLPVL
33
2
55
17
5.10
(1,27 – 
20,53)
0.0230a
*1101 HPVLLPVL
24
5
64
14 0.9322
a
*0101 HPVLLPVL
20
6
68
13 0.3947
b
*1201 HPVLLPVL
23
0
65
19 ------- 0.0111
b
*0201 HPVLLPVL
7
7
81
12
0.15
(0.05 – 
0.48)
0.0030b
*0902 HPVLLPVL
7
2
81
17 0.6594
b
*0601 HPVLLPVL
5
2
83
17 0.6051
b
*1801 HPVLLPVL
5
1
83
18 1
b
*2703 HPVLLPVL
4
1
84
18 1
b
*3103 HPVLLPVL
4
0
84
19 1
b
*14011 HPVLLPVL
1
2
87
17 0.0807
b
*1001/*1002 HPVLLPVL
1
2
87
17 0.0807
b
*1402 HPVLLPVL
2
0
86
19 1
b
*2707 HPVLLPVL
1
1
87
18 0.3250
b
*0701 HPVLLPVL
1
0
87
19 1
b
*1701 HPVLLPVL
0
1
88
18 0.1776
b
*2003 HPVLLPVL
1
0
87
19 1
b
Values in bold are statistically significant – odds ratios with p < 0.05
a Chi2 test
b Exact Fisher test
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Distribution of BoLA DRB3.2 alleles significantly 
associated with PVL
BoLA DRB3.2*1501, *1201, and *0201 were significantly 
associated with PVL. Contrasts were estimated in order to 
compare absence and presence of each one in homozygous 
and heterozygous form.
BoLA DRB3.2*1501 allele is present in heterozygosis 
in 94% of HPVL animals; animals that carry it are about 
5 times more likely to have HPLP (Chi2 test: p = 0.0230) 
(Table 3). BoLA DRB3.2*1201 allele is present only in 
HPVL animals (Fisher exact test: p = 0.0187) (Table 4). 
BoLA DRB3.2*0201 allele is present in heterozygous in 
50% of HPVL animals and 50% of LPVL animals; among 
animals that do not possess this allele, 87% have HPVL 
(Fisher exact test: p = 0.0030) (Table 5). Thus, animals that 
have *0201 allele would be protected to develop HPVL.
Table 3 – Distribution of BoLA DRB3.2*1501
                    PVL
Genotype HPVL LPVL Total
Homozygote 0 0 0
Heterozygote 33 2 35
Absence 55 17 72
Total 88 19 107
Chi2 test: p = 0.0230; OR 5.10 (CI 1.27 – 20.53)
Table 4 – Distribution of BoLA DRB3.2*1201
                     PVL
Genotype HPVL LPVL Total
Homozygote 1 0 1
Heterozygote 22 0 22
Absence 65 19 84
Total 88 19 107
Fisher exact test: p = 0.0187; OR between groups cannot be estimated
Table 5 – Distribution of BoLA DRB3.2*0201
                      PVL
Genotype HPVL LPVL Total
Homozygote 0 0 0
Heterozygote 7 7 14
Absence 81 12 93
Total 88 19 107
Fisher exact test: p = 0.0030; OR 0.15 (CI 0.05 – 0.48)
A logistic regression model was run with the BoLA 
DRB3.2*0201 and *1501 alleles as the independent 
variables, and the HPVL profile as the dependent variable. 
This analysis indicated that *0201 allele is a protective factor 
(p = 0.0024), while *1501 allele is a risk factor (p = 0.0341) 
for HPVL profile (Table 6). Thus, genes that best explain 
the PVL are BoLA DRB3.2*0201 (as a protection factor) 
and *1501 (as a risk factor), with no significant interaction 
estimated between them (p = 0.957).
Table 6 – Logistic regression for BoLA DRB3.2*0201 or *1501 
alleles and HPVL profile
Independent 
variables
OR
(CI 95%) p value
BoLA DRB3.2*0201 0.13(0.04 – 0.49) 0.0024
BoLA DRB3.2 *1501 5.65(1.14 – 28.01) 0.0341
Discussion
 This study analysed the distribution of BoLA DRB3.2 
alleles in an Argentinean Holstein herd and its association 
with the BLV proviral load. In this group of animals 
(N = 107), we identified 18 alleles and BoLA DRB3.2*1001 
had the highest allelic frequency (17.29%). There is not 
too much information about the allelic diversity of BoLA 
DRB3 class II gene in different cattle breeds. As far as 
it is known, only one study described this diversity in 
South American Holstein populations (TAKESHIMA et 
al., 2015). These authors found that BoLA DRB3*1501 
appeared to be widely spread in the cattle of countries 
of South America: 18.2% in Bolivia, 17.7% in Paraguay, 
21.4% in Peru, 21,7% in Chile, and 14.7% in Argentina. 
In the present investigation we found a slightly higher 
frequency of this allele in our population (16.36%). BoLA 
DRB3*0101 and *1101 were also in high frequency in these 
Holstein population of South American countries. Even 
though BoLA DRB3*0101 was the most frequently found 
in Argentina (17.7%), its presence was lower by one third 
in our population (12.15%). The greatest differences in 
allelic frequency between Takeshima’s and in the present 
study were in BoLA DRB3*1201 (7.3% vs 11.21%), *1001 
(5% vs 17.29%), and *0201 (3.2% vs 6.54%). The highest 
frequency of the analysed alleles found in this research 
could be a result of the selection for trait parameters 
applied in our herd. And this fact might have implications 
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on susceptibility or resistance to diseases, immunological 
and production trails, and vaccine responses.
Related to the infection with BLV in Holstein breed, 
several studies have shown that the susceptibility to PL 
was associated with the presence of BoLA DRB3*0101, 
*1501 or 03, *1101 or 02, and *1201 (XU et al., 1993; 
ZANOTTI et al., 1996; MIRSKY et al., 1998; JULIARENA 
et al., 2008; PANEI et al., 2009; NIKBAKHT BRUJENI 
et al., 2016). In the present study, BoLA DRB3*1201 was 
the most significantly associated with HPVL (p = 0.0111), 
and this might be due to the fact that its frequency in the 
investigated population was about one third higher than 
in other Argentinean Holstein populations (11.21% vs 
7.3%, respectively) (TAKESHIMA et al., 2015). In this 
investigation we also found a strong association between 
HPVL and the presence of BoLA DRB3*1501 (p = 0.0230). 
These two alleles are the most frequently associated with 
susceptibility to PL or HPVL in BLV-infected animals 
from different cattle breeds (XU et al., 1993; SULIMOVA 
et al., 1995; ZANOTTI et al., 1996; UDINA et al., 2003; 
JULIARENA et al., 2008). BoLA DRB3*1001 had the 
highest frequency in the investigated herd, and in the 
literature it was referred as a susceptible (XU et al., 1993; 
UDINA et al., 2003) or a neutral allele (XU et al., 1993) for 
PL development. However, no association with BLV status 
could be established in BoLA DRB3*1001 carrier animals 
from the present study. In Japanese cattle, Miyasaka et 
al. (2013) found that *1601 allele was associated with 
HPVL, but in this investigation no animals were identified 
carrying this allele.
Resistance to PL or an LPVL profile were associated 
with alleles that are generally less distributed in cattle 
population. In the present investigation we found a strong 
association between DRB3.2*0201 and LPVL (p = 0.030). It 
is possible to speculate that the absence of this allele could 
be an indicative of a putative development of HPVL (Table 
5). Panei et al. (2009) studied a herd of 81 Argentinean 
Holstein animals by PCR-RFLP and mentioned BoLA 
DRB3.2*11, *23, *28, *25, and *40 (ISAG *0902, *2703, 
*0701 or 03, and non-classified respectively) as associated 
with PL resistance; but in the present investigation we 
did not find the same results. Even though several studies 
cited *1101 linked to PL susceptibility in different cattle 
breeds (XU et al., 1993; SULIMOVA et al., 1995; UDINA 
et al., 2003; PANEI et al., 2009; NIKBAKHT BRUJENI et 
al., 2016), it was associated with LPVL in Japanese cattle 
(MIYASAKA et al., 2013). In the present investigation 
we found a significant number of animals carrying this 
allele in our herd, compared to the population of Holstein 
in Argentina (TAKESHIMA et al., 2015); however, no 
association could be established between allele BoLA 
DRB3.2*1101 and BLV PVL. In the literature BoLA 
DRB3.2*0902 (or *11 determined by PCR-RFLP) allele 
was most strongly associated with PL resistance or LPVL 
profile in Holstein cattle (XU et al., 1993; ZANOTTI et 
al., 1996; MIRSKY et al., 1998; JULIARENA et al., 2008; 
PANEI et al., 2009; MIYASAKA et al., 2013). In the present 
investigation we did not find this association, which could 
be due to a lower frequency of presentation of *0902 allele 
in this herd in comparison with the Argentinean Holstein 
populations (4.21% vs 6.4%, respectively) (TAKESHIMA 
et al., 2015).
Genetic selection for BoLA DRB3.2*0902 allele has 
been proposed to breed cattle that are resistant to HPVL 
development (JULIARENA et al., 2016). Evidences from 
the literature reveal that the polymorphism in the BoLA 
class II gene influences immune response by peptide 
binding, antigen presentation, T-cell repertoire, and 
cytokine networks (TAKESHIMA; AIDA, 2006). Thus, 
allelic differences in BLV-infected animals may play an 
important role in the development of effective immune 
responses. However, BLV-resistance might not be only 
related to a single allele of the DRB3.2 gene. Indeed, 
about 19% of cattle carrying the BoLA DRB3.2*0902 
allele develop HPVL (JULIARENA et al., 2008). It must 
be considered that expression of BoLA DRB3 might be 
influenced by polymorphisms in other surrounding genes. 
An important gene of the immune system that has been 
linked to the BoLA region is the promoter region of tumor 
necrosis factor-alpha (TNF-α): both genes are located in 
the q22 arm of the bovine chromosome 23 and in linkage 
disequilibrium (LENDEZ et al., 2015). Concerning BLV 
infection, TNF-α is closely related with the immune 
response against viral dissemination, stimulating the 
elimination of infected lymphocytes (KABEYA et al., 
1999). Konnai et al. (2006) described that genotype 
G/G in position -824 of the promoter region of TNF-α 
was associated with low transcriptional activity of the 
promoter region. The frequency of this genotype G/G 
was higher in individuals with BLV-induced lymphoma 
than in asymptomatic carrier individuals. Moreover, a 
tendency toward an increased BLV provirus load in cattle 
with the TNF-α –824 G/G homozygote was observed 
when compared to the A/A homozygote or genotype A/G. 
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Lendez et al. (2015), analysing a large population of cattle 
with HPVL or LPVL, revealed a significant association 
between LPVL and a low frequency of the G/G genotype 
at position -824. That means that an animal carrying this 
polymorphism most probably belongs to the HPVL group. 
In the present study we also analysed the polymorphism 
in the promoter region of TNF-α; however, no statistical 
differences were found between animals with HPVL or 
LPVL (data not shown), probably due to the small number 
of animals with LPVL. Taking together, it seems that 
several polymorphisms in different genes may contribute 
to develop a resistance profile in BLV-infected cattle.
On the other hand, other issues like production traits 
improvement, resistance to mastitis pathogens, somatic 
cell counts and milk yield have also been related to specific 
BoLA alleles (DIETZ et al., 1997; RUPP et al., 2007; 
YOSHIDA et al., 2009; BALTIAN et al., 2012; YOSHIDA 
et al., 2012). However, some controversies exist between 
different studies. Abdalla et al. (2016) communicated a 
genome-wide association mapping in order to analyse 
BLV incidence in US Holstein cattle population, together 
with milk yield and somatic cell score, combining pedigree 
and molecular marker information, for the detection of 
genomic regions and gene pathways associated with the 
disease. The study revealed BLV incidence as a complex 
trait, possibly modulated by several genes of small effects.
Conclusions
The association between BoLA polymorphism and 
development of a BLV infection profile was investigated. 
Genes that best explain the PVL in this population resulted 
BoLA DRB3.2*0201 (as a protection factor) and *1501 (as 
a risk factor). Allelic differences may play an important 
role in the development of effective immune responses, 
against BLV and other pathogens. Thus, genetic selection 
based on specific BoLA alleles should be implemented with 
great caution considering the variable effects of these genes 
on a wide range of diseases and production traits. A better 
understanding of how BoLA polymorphism contributes 
to the development of effective immune response and the 
establishment of a BLV status is desirable to schedule and 
evaluate control measures.
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